D.A. Sychev (1), K.B. Mirzaev (1), D.V. Ivashchenko (1), Yu.Yu. Kiselev (2), V.A. Otdelenov (1), A.V. Kryukov (1), V.M. Tsvetov (3), K.A. Zagorodnikova (4), A.V. Matveev (1), S.V. Glagolev (5)
“PharmaCOVID” – information center for pharmacotherapy of patients with new coronavirus infection COVID-19
|
10-14 |
REVIEWS |
|
Yu.G. Belotserkovskaya, A.I. Sinopalnikov
COVID-19: lessons we are learning today (as of April 27, 2020)
|
15-28 |
I.V. Leshchenko (1, 2), V.E. Evdokimov (1)
The place of nebulizer therapy in clinical practice
|
29-37 |
CLINICAL GUIDELINES |
|
A.I. Sinopalnikov
ATS/IDSA-2019 recommendations for the management of adult patients with community-acquired pneumonia: 12 years later
|
38-45 |
S.V. Morozova, L.A. Keda
Prevention and treatment of upper respiratory tract diseases complicating the course of acute respiratory infections
|
46-50 |
E.V. Mirzabekyan (1), G.D. Tarasova (2)
Allergic rhinitis from the standpoint of an otorhinolaryngologist
|
51-57 |
M.F. Kinyaykin (1), S.A. Danilenko (2), Yu.Yu. Khizhnyak (3), I.V. Naumova (1)
The role of anti-IL-5Rα treatment with benralizumab in severe asthma
|
58-64 |
ORIGINAL ARTICLES |
|
V.M. Svistushkin (1), S.V. Starostina (1), M.V. Svistushkin (1), S.F. Timashev (2), A.B.Shekhter (3), A.L. Fayzullin (3), A.A. Pobivantseva (1), A.A. Lunicheva (1), G.V. Lebedeva (1)
The effect of mesenchymal stromal cells on the restoration of the structure of the vocal folds with cicatricial changes. Controlled pilot study
|
65-71 |
V.M. Svistushkin (1), S.V. Starostina (1), L.V. Selezneva (1), O.I. Baum (2), E.N. Sobol (2), Yu.M. Aleksandrovskaya (2), A.V. Starostin (3)
The use of modified autografts for plastic closure of laryngotracheal defects: an experimental study
|
72-76 |
D.A. Sychev (1), O.D. Ostroumova (1, 2), A.I. Kochetkov (1), A.P. Pereverzev (1), T.M. Ostroumova (2), M.V. Klepikova (1), I.A. Alyautdinova (1), E.Yu. Ebzeeva (1)
Drug-induced diseases: epidemiology and urgency of the problem
|
77-84 |
A.V. Emelyanov, E.V. Leshenkova, G.R. Sergeeva
Asthma in the elderly and senile age: features of diagnosis and treatment
|
85-94 |
A.I. Kryukov, N.L. Kunelskaya, A.B. Turovsky, Yu.V. Luchsheva
Persistent allergic rhinitis as a factor causing and complicating the course of acute and chronic bacterial diseases of ENT organs
|
95-101 |
V.M. Svistushkin, E.S. Morozova
The use of nasal decongestants in ENT practice
|
102-104 |
N.A. Karoli, A.P. Rebrov
Beta-blockers in patients with chronic obstructive pulmonary disease: for whom, when, how?
|
106-113 |
E.V. Sinkov, V.M. Svistushkin, T.Kh. Shadyev, I.V. Stozhkova
Mucoactive therapy in the practice of an otorhinolaryngologist
|
114-116 |
V.A. Sergeeva (1), T.N. Pankova (2), T.V. Gavrishchuk (2)
Pulmonary mycobacteriosis in a patient with bronchiectatic disease: a clinical case
|
117-123 |